Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$799 Sell
7
-313
-98% -$36.9K ﹤0.01% 2208
2026
Q2
$34.1K Sell
320
-4
-1% -$484 ﹤0.01% 1500
2026
Q1
$53K Sell
324
-16
-5% -$2.46K ﹤0.01% 1302
2025
Q4
$59.2K Sell
340
-224
-40% -$40.9K ﹤0.01% 1291
2025
Q3
$81.2K Hold
564
– – ﹤0.01% 1166
2025
Q2
$56.8K Sell
564
-342
-38% -$26.2K ﹤0.01% 1367
2025
Q1
$69.1K Buy
906
+75
+9% +$5.74K ﹤0.01% 1170
2024
Q4
$57.4K Sell
831
-1,128
-58% -$81.2K ﹤0.01% 1224
2024
Q3
$131K Buy
1,959
+1,879
+2,349% +$139K ﹤0.01% 1074
2024
Q2
$2.17K Buy
+80
New +$3.1K ﹤0.01% 2425
2024
Q1
– Sell
-38
Closed -$1K – 2455
2023
Q4
$1K Buy
+38
New +$985 ﹤0.01% 2342
2023
Q3
– Sell
-8
Closed – – 2157
2023
Q2
$0 Buy
+8
New +$152 ﹤0.01% 2276
2022
Q4
– Sell
-30
Closed -$1K – 2345
2022
Q3
$1K Buy
+30
New +$719 ﹤0.01% 1936

Other funds holding INSM

Blue Trust's INSM Position: Q3 2026 in Review

Blue Trust reduced its Insmed (INSM) stake by 98% in Q3 2026, selling an estimated $36.9K and leaving 7 shares worth $799. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Blue Trust first reported a position in INSM in Q3 2022 and has held it in 13 quarters since. The position peaked at $131K in Q3 2024. 561 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Blue Trust held 7 shares of Insmed worth $799 as of Q3 2026.
  • Blue Trust sold 313 Insmed shares in Q3 2026, an estimated $36.9K.
  • Insmed made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2208 holding.
  • Blue Trust first reported a position in Insmed in Q3 2022 and has held it in 13 quarters since.
  • Blue Trust's Insmed position peaked at $131K in Q3 2024.
  • 561 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.